Regional differences in cerebrovascular reactivity to acetazolamide in Alzheimer's disease

Journal of Clinical Neuroscience

Volumn 6, Issue 5, 1999, Pages 380-381

  Oishi, Minoru ^a   Mochizuki, Yoko ^a   Takasu, Toshiaki ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Acetazolamide; Alzheimer's disease; Cerebral blood flow; Xenon computed tomography

Indexed keywords

EID: 7944238069     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(99)90030-9     Document Type: Article

References (18)

1. Bonte FJ, Devous MD Sr, Reisch JS et al. The effect of acetazolamide on regional cerebral blood flow in patients with Alzheimer's disease or stroke as measured by single-photon emission computed tomography. Invest Radiol 1989; 24: 99-103.
2. Stoppe G, Schütze R, Kögler A et al. Cerebrovascular reactivity to acetazolamide in (senile) dementia of Alzheimer's type: relationship to disease severity. Dementia 1995; 6: 73-82.
3. Johnson DW, Stringer WA, Marks MP, Yonas H, Good WF, Gur D. Stable xenon CT cerebral blood flow imaging: rationale for and role in clinical decision making. AJNR 1991; 12: 201-213.
4. McKhann G, Drachman D. Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neúrology 1984; 34: 939-944.
5. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state" a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975; 12: 189-198.
6. Kashiwaki S, Yamashita T, Nakano S et al. The wash-in/washout protocol in stable xenon CT cerebral blood flow studies. AJNR 1992; 13: 49-53.
7. Oishi M, Mochizuki Y, Hara M, Du C-M, Takasu T. Effects of intravenous L-dopa on P300 and regional cerebral blood flow in parkinsonism. Intern J Neuroscience 1996; 85: 147-154.
8. Kawamura J, Meyer JS, Terayama Y, Weathers S. Leuko-araiosis and cerebral hypoperfusion compared in elderly normals and Alzheimer's dementia. J Am Geriatr Soc 1992; 40: 375-380.
9. Tachibana H, Meyer JS, Okayasu H, Shaw TG, Kandula P, Rogers RL. Xenon contrast CT-CBF scanning of the brain differentiates normal age-related changes from multi-infarct dementia and senile dementia of Alzheimer type. J Gerontol 1984; 39: 415-423.
10. O'Brien JT, Eagger S, Syed GMS, Sahakian BJ, Levy R. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992: 55: 1182-1187.
11. Syed GMS, Eagger S, O'Brien J, Barrett JJ, Levy R. Patterns of regional cerebral blood flow in Alzheimer's disease. Nucl Med Commun 1992; 13: 656-663.
12. Kawabata K, Tachibana H, Sugita M, Fukuchi M. A comparative I-123 IMP SPECT study in Binswanger's disease and Alzheimer's disease. Clin Nucl Med 1993; 18: 329-336.
13. Claus JJ, van Harskamp F, Breteler MMB et al. The diagnostic value of SPECT with Tc 99 m HMPAO in Alzheimer's disease: a population-based study. Neurology 1994; 44: 454-461.
14. 99mTc-HMPAO-SPECT in the diagnosis of senile dementia of Alzheimer's type - a study under clinical routine conditions. J Neural Transm Gen Sect 1995; 99: 195-211.
15. Kuwabara Y, Ichiya Y, Otsuka M, Masuda K, Ichimiya A, Fujishima M. Cerebrovascular responsiveness to hypercapnia in Alzheimer's dementia and vascular dementia of the Binswanger type. Stroke 1992; 23: 594-598.
16. Vorstrup S, Henriksen L, Paulson OB. Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. J Clin Invest 1984; 74: 1634-1639.
17. Frankel HM, Gracia E, Malik F, Weiss JK, Weis HR. Effect of acetazolamide on cerebral blood flow and capillary patency. J Appl Physiol 1992; 73: 1756-1761.
18. Sullivan HG, Kingsbury TB, Morgan ME et al. The rCBF response to Diamox in normal subjects and Cerebrovascular disease patients. J Neurosurg 1987; 67: 525-534.